ARDX
Price
$3.58
Change
-$0.04 (-1.10%)
Updated
Sep 11 closing price
Capitalization
923.02M
47 days until earnings call
Intraday BUY SELL Signals
IMNM
Price
$24.67
Change
-$0.30 (-1.20%)
Updated
Sep 11 closing price
Capitalization
2.8B
65 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARDX vs IMNM

ARDX vs IMNM Comparison Chart in %
View a ticker or compare two or three
VS
ARDX vs. IMNM commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Buy and IMNM is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.8B) has a higher market cap than ARDX($923M). IMNM YTD gains are higher at: 14.851 vs. ARDX (-38.593). ARDX has higher annual earnings (EBITDA): -23.43M vs. IMNM (-267.04M). IMNM has more cash in the bank: 520M vs. ARDX (282M). IMNM has less debt than ARDX: IMNM (4.74M) vs ARDX (256M). ARDX has higher revenues than IMNM: ARDX (451M) vs IMNM (0).
ARDXIMNMARDX / IMNM
Capitalization923M2.8B33%
EBITDA-23.43M-267.04M9%
Gain YTD-38.59314.851-260%
P/E RatioN/AN/A-
Revenue451M0-
Total Cash282M520M54%
Total Debt256M4.74M5,401%
FUNDAMENTALS RATINGS
ARDX vs IMNM: Fundamental Ratings
ARDX
IMNM
OUTLOOK RATING
1..100
6087
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
7873
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
8436
P/E GROWTH RATING
1..100
35100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMNM's Valuation (64) in the null industry is somewhat better than the same rating for ARDX (100) in the Biotechnology industry. This means that IMNM’s stock grew somewhat faster than ARDX’s over the last 12 months.

IMNM's Profit vs Risk Rating (73) in the null industry is in the same range as ARDX (78) in the Biotechnology industry. This means that IMNM’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's SMR Rating (97) in the Biotechnology industry is in the same range as IMNM (98) in the null industry. This means that ARDX’s stock grew similarly to IMNM’s over the last 12 months.

IMNM's Price Growth Rating (36) in the null industry is somewhat better than the same rating for ARDX (84) in the Biotechnology industry. This means that IMNM’s stock grew somewhat faster than ARDX’s over the last 12 months.

ARDX's P/E Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for IMNM (100) in the null industry. This means that ARDX’s stock grew somewhat faster than IMNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARDXIMNM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
Bullish Trend 26 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ARDX: $3.58 vs. IMNM: $24.67)
Brand notoriety: ARDX and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 131% vs. IMNM: 63%
Market capitalization -- ARDX: $923.02M vs. IMNM: $2.8B
ARDX [@Biotechnology] is valued at $923.02M. IMNM’s [@Biotechnology] market capitalization is $2.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green while IMNM’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than ARDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 4 bullish TA indicator(s).

  • ARDX’s TA Score: 5 bullish, 3 bearish.
  • IMNM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ARDX is a better buy in the short-term than IMNM.

Price Growth

ARDX (@Biotechnology) experienced а -5.29% price change this week, while IMNM (@Biotechnology) price change was -7.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ARDX is expected to report earnings on Oct 29, 2026.

IMNM is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ARDX
Daily Signal:
Gain/Loss:
IMNM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTTX27.510.20
+0.73%
Artisan Focus Fund Investor
AREWX27.990.18
+0.65%
American Century Real Estate R
ICMBX14.32N/A
N/A
Intrepid Capital Investor
OLGCX48.43N/A
N/A
JPMorgan Large Cap Growth C
PRDMX47.11N/A
N/A
T. Rowe Price Diversified Mid Cap Gr

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with VCYT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-1.10%
VCYT - ARDX
45%
Loosely correlated
-2.76%
CABA - ARDX
36%
Loosely correlated
-0.36%
RNAC - ARDX
35%
Loosely correlated
-2.85%
ELVN - ARDX
34%
Loosely correlated
-3.40%
IMNM - ARDX
32%
Poorly correlated
-1.20%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-1.20%
KYTX - IMNM
50%
Loosely correlated
-1.22%
VKTX - IMNM
48%
Loosely correlated
-0.47%
KURA - IMNM
47%
Loosely correlated
-1.56%
EDIT - IMNM
47%
Loosely correlated
+1.89%
SANA - IMNM
45%
Loosely correlated
+1.29%
More